| 30.28 -0.67 (-2.16%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 39.24 | 1-year : | 42.02 |
| Resists | First : | 33.6 | Second : | 35.97 |
| Pivot price | 32.57  |
|||
| Supports | First : | 29.76 | Second : | 24.76 |
| MAs | MA(5) : | 31.07 |
MA(20) : | 33.1 |
| MA(100) : | 40.23 |
MA(250) : | 38.14  |
|
| MACD | MACD : | -1.5 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 17.6 |
D(3) : | 22.8 |
| RSI | RSI(14): 33.5 |
|||
| 52-week | High : | 55.75 | Low : | 25.12 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ OMCL ] has closed above bottom band by 18.2%. Bollinger Bands are 27.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 31 - 31.18 | 31.18 - 31.32 |
| Low: | 29.67 - 29.92 | 29.92 - 30.1 |
| Close: | 29.96 - 30.32 | 30.32 - 30.59 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Thu, 17 Apr 2025
Wells Fargo Adjusts Omnicell (OMCL) Price Target Amid Cost Concerns | OMCL Stock News - GuruFocus
Tue, 15 Apr 2025
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 | OMCL Stock News - GuruFocus
Mon, 14 Apr 2025
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 - Business Wire
Mon, 14 Apr 2025
First Look: Omnicell Sets Date for Q1 2025 Financial Results - Stock Titan
Thu, 10 Apr 2025
Here's Why Omnicell (OMCL) is a Strong Value Stock - Yahoo Finance
Thu, 10 Apr 2025
Here's Why Omnicell (OMCL) is a Strong Value Stock - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 47 (M) |
| Shares Float | 46 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 102.2 (%) |
| Shares Short | 1,640 (K) |
| Shares Short P.Month | 1,830 (K) |
| EPS | 0.27 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 26.8 |
| Profit Margin | 1.1 % |
| Operating Margin | 4.4 % |
| Return on Assets (ttm) | 0.1 % |
| Return on Equity (ttm) | 1 % |
| Qtrly Rev. Growth | 18.6 % |
| Gross Profit (p.s.) | 10.15 |
| Sales Per Share | 23.69 |
| EBITDA (p.s.) | 1.34 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 188 (M) |
| Levered Free Cash Flow | 147 (M) |
| PE Ratio | 112.14 |
| PEG Ratio | 0 |
| Price to Book value | 1.12 |
| Price to Sales | 1.27 |
| Price to Cash Flow | 7.55 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|